165 related articles for article (PubMed ID: 36692718)
1. Association between perfluoroalkyl substances exposure and the prevalence of nonalcoholic fatty liver disease in the different sexes: a study from the National Health and Nutrition Examination Survey 2005-2018.
E L; Zhang S; Jiang X
Environ Sci Pollut Res Int; 2023 Mar; 30(15):44292-44303. PubMed ID: 36692718
[TBL] [Abstract][Full Text] [Related]
2. Perfluoroalkyl substance (PFAS) exposure and risk of nonalcoholic fatty liver disease in the elderly: results from NHANES 2003-2014.
Wu Z; Ouyang T; Liu H; Cao L; Chen W
Environ Sci Pollut Res Int; 2023 May; 30(23):64342-64351. PubMed ID: 37067713
[TBL] [Abstract][Full Text] [Related]
3. Perfluoroalkyl substances and sex hormones in postmenopausal women: NHANES 2013-2016.
Wang Y; Aimuzi R; Nian M; Zhang Y; Luo K; Zhang J
Environ Int; 2021 Apr; 149():106408. PubMed ID: 33548847
[TBL] [Abstract][Full Text] [Related]
4. Association of exposure to multiple perfluoroalkyl and polyfluoroalkyl substances and glucose metabolism in National Health and Nutrition Examination Survey 2017-2018.
Tian Q; Yang Y; An Q; Li Y; Wang Q; Zhang P; Zhang Y; Zhang Y; Mu L; Lei L
Front Public Health; 2024; 12():1370971. PubMed ID: 38633237
[TBL] [Abstract][Full Text] [Related]
5. Exposure to perfluoroalkyl and polyfluoroalkyl substances and estimated glomerular filtration rate in adults: a cross-sectional study based on NHANES (2017-2018).
Liang Y; Zhou H; Zhang J; Li S; Shen W; Lei L
Environ Sci Pollut Res Int; 2023 Apr; 30(20):57931-57944. PubMed ID: 36971931
[TBL] [Abstract][Full Text] [Related]
6. Association between per- and polyfluoroalkyl substances exposure and prevalence of chronic obstructive pulmonary disease: The mediating role of serum albumin.
Wang Y; Zhang J; Zhang J; Hou M; Kong L; Lin X; Xu J; Yan C; Lin F; Ke S
Sci Total Environ; 2024 May; 925():171742. PubMed ID: 38494022
[TBL] [Abstract][Full Text] [Related]
7. Association of Perfluoroalkyl Substances, Bone Mineral Density, and Osteoporosis in the U.S. Population in NHANES 2009-2010.
Khalil N; Chen A; Lee M; Czerwinski SA; Ebert JR; DeWitt JC; Kannan K
Environ Health Perspect; 2016 Jan; 124(1):81-7. PubMed ID: 26058082
[TBL] [Abstract][Full Text] [Related]
8. Perfluoroalkyl substances and endometriosis in US women in NHANES 2003-2006.
Campbell S; Raza M; Pollack AZ
Reprod Toxicol; 2016 Oct; 65():230-235. PubMed ID: 27544573
[TBL] [Abstract][Full Text] [Related]
9. PFOA is associated with diabetes and metabolic alteration in US men: National Health and Nutrition Examination Survey 2003-2012.
He X; Liu Y; Xu B; Gu L; Tang W
Sci Total Environ; 2018 Jun; 625():566-574. PubMed ID: 29291571
[TBL] [Abstract][Full Text] [Related]
10. Association between perfluoroalkyl substances concentration and bone mineral density in the US adolescents aged 12-19 years in NHANES 2005-2010.
Xiong X; Chen B; Wang Z; Ma L; Li S; Gao Y
Front Endocrinol (Lausanne); 2022; 13():980608. PubMed ID: 36277702
[TBL] [Abstract][Full Text] [Related]
11. PPARα/ACOX1 as a novel target for hepatic lipid metabolism disorders induced by per- and polyfluoroalkyl substances: An integrated approach.
Yang W; Ling X; He S; Cui H; Yang Z; An H; Wang L; Zou P; Chen Q; Liu J; Ao L; Cao J
Environ Int; 2023 Aug; 178():108138. PubMed ID: 37572494
[TBL] [Abstract][Full Text] [Related]
12. Systematic review and meta-analysis of epidemiologic data on vaccine response in relation to exposure to five principal perfluoroalkyl substances.
Crawford L; Halperin SA; Dzierlenga MW; Skidmore B; Linakis MW; Nakagawa S; Longnecker MP
Environ Int; 2023 Feb; 172():107734. PubMed ID: 36764183
[TBL] [Abstract][Full Text] [Related]
13. Time trends over 2003-2014 in the concentrations of selected perfluoroalkyl substances among US adults aged ≥20 years: Interpretational issues.
Jain RB
Sci Total Environ; 2018 Dec; 645():946-957. PubMed ID: 30248883
[TBL] [Abstract][Full Text] [Related]
14. Per- and poly-fluoroalkyl substances (PFASs) in follicular fluid from women experiencing infertility in Australia.
Kim YR; White N; Bräunig J; Vijayasarathy S; Mueller JF; Knox CL; Harden FA; Pacella R; Toms LL
Environ Res; 2020 Nov; 190():109963. PubMed ID: 32745751
[TBL] [Abstract][Full Text] [Related]
15. Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study.
Starling AP; Engel SM; Whitworth KW; Richardson DB; Stuebe AM; Daniels JL; Haug LS; Eggesbø M; Becher G; Sabaredzovic A; Thomsen C; Wilson RE; Travlos GS; Hoppin JA; Baird DD; Longnecker MP
Environ Int; 2014 Jan; 62():104-12. PubMed ID: 24189199
[TBL] [Abstract][Full Text] [Related]
16. Association of single and multiple prefluoroalkyl substances exposure with preterm birth: Results from a Chinese birth cohort study.
Liao Q; Tang P; Song Y; Liu B; Huang H; Liang J; Lin M; Shao Y; Liu S; Pan D; Huang D; Qiu X
Chemosphere; 2022 Nov; 307(Pt 1):135741. PubMed ID: 35863418
[TBL] [Abstract][Full Text] [Related]
17. Prenatal exposure to perfluoroalkyl substances and birth outcomes in a Spanish birth cohort.
Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Martinez D; Costa O; Santa-Marina L; Pereda-Pereda E; Schettgen T; Sunyer J; Vrijheid M
Environ Int; 2017 Nov; 108():278-284. PubMed ID: 28917208
[TBL] [Abstract][Full Text] [Related]
18. Perfluoroalkyl substances follow inverted U-shaped distributions across various stages of glomerular function: Implications for future research.
Jain RB; Ducatman A
Environ Res; 2019 Feb; 169():476-482. PubMed ID: 30530087
[TBL] [Abstract][Full Text] [Related]
19. Perfluoroalkyl substances exposure and hearing impairment in US adults.
Ding N; Park SK
Environ Res; 2020 Aug; 187():109686. PubMed ID: 32474307
[TBL] [Abstract][Full Text] [Related]
20. Associations between lipid/lipoprotein levels and perfluoroalkyl substances among US children aged 6-11 years.
Jain RB; Ducatman A
Environ Pollut; 2018 Dec; 243(Pt A):1-8. PubMed ID: 30170203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
